CM
GILD icon

Capula Management’s Gilead Sciences GILD Stock Holding History

Capula Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$321K Sell
2,300
-200
-8% -$28K ﹤0.01% 627
2025
Q4 		$307K Buy
2,500
+400
+19% +$48.6K ﹤0.01% 491
2025
Q3 		$233K Buy
2,100
+700
+50% +$79.6K ﹤0.01% 577
2025
Q2 		$155K Buy
+1,400
New +$149K ﹤0.01% 426
2023
Q3 		– Sell
-4,100
Closed -$316K – 568
2023
Q2 		$316K Sell
4,100
-54,500
-93% -$4.35M 0.01% 357
2023
Q1 		$4.86M Sell
58,600
-1,800
-3% -$149K 0.06% 240
2022
Q4 		$5.19M Sell
60,400
-360,100
-86% -$28.5M 0.07% 252
2022
Q3 		$25.9M Buy
420,500
+348,500
+484% +$22M 0.35% 68
2022
Q2 		$4.45M Buy
+72,000
New +$4.46M 0.08% 208
2021
Q2 		– Sell
-51,900
Closed -$3.35M – 812
2021
Q1 		$3.35M Buy
+51,900
New +$3.35M 0.07% 252

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capula Management's GILD Position: Q4 2025 in Review

Capula Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 6,009 shares — an estimated $730K sold.

Capula Management first reported a position in GILD in Q3 2019 and held it in 16 quarters. The position peaked at $7.97M in Q3 2020. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Capula Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Capula Management sold 6,009 Gilead Sciences shares in Q4 2025, an estimated $730K.
  • Capula Management first reported a position in Gilead Sciences in Q3 2019 and held it in 16 quarters.
  • Capula Management's Gilead Sciences position peaked at $7.97M in Q3 2020.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Capula Management's 13F filing for Q4 2025, filed 13 Feb 2026.